2026 Perinatal Substance Use Webinar Series

Pediatric Management of Prenatal Substance Exposure

Prenatal substance exposure can have a significant impact on the infant. The first steps in managing infants exposed to substances prenatally are to determine the substances and to recognize the clinical presentation of withdrawal. With early recognition of Neonatal Opioid Withdrawal Syndrome (NOWS), providers can select the strategy that best supports the infant and family. This presentation describes how management of NOWS impacts outcome and how toxicology testing can impact care.

Register to unlock the course, then click ‘Continue.’ Course materials are available at the bottom of this page.
Write your awesome label here.
Patrick Jones - Course author
Meet the instructor

Kelsey Ryan, MD

Kelsey Ryan, MD, is a mom, pediatrician, and newborn nursery medical director. She is an Associate Professor of Pediatrics at the Medical College of Wisconsin. She received her MD from the University of Minnesota Medical School and completed a residency in Pediatrics at the University of South Florida. She has a strong interest in the care of infants exposed to substances in utero.

 

The speaker has no relevant financial relationships with ineligible companies.*

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Identify the clinical presentation of NOWS
  • Contrast diagnostic criteria for a diagnosis of NAS vs NOWS
  • Distinguish how management of NOWS impacts outcomes
  • Describe how toxicology testing impacts care


Accreditation Statement

Continuing Medical Education

The Wisconsin Association for Perinatal Care (WAPC) is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. The Wisconsin Association for Perinatal Care (WAPC) designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*
*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.

Course Information

This webinar was recorded on 19 May 2026.

The expiration date for this course is 19 May 2029.